160415
3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine
≥99%
Synonym(s):
5,6-Diphenyl-3-(2-pyridyl)-1,2,4-triazine, PDT
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C20H14N4
CAS Number:
Molecular Weight:
310.35
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
213-878-7
Beilstein/REAXYS Number:
542151
MDL number:
Assay:
≥99%
assay
≥99%
mp
191-193 °C (lit.)
functional group
phenyl
SMILES string
c1ccc(cc1)-c2nnc(nc2-c3ccccc3)-c4ccccn4
InChI
1S/C20H14N4/c1-3-9-15(10-4-1)18-19(16-11-5-2-6-12-16)23-24-20(22-18)17-13-7-8-14-21-17/h1-14H
InChI key
OTMYLOBWDNFTLO-UHFFFAOYSA-N
General description
3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine (PDT) reacts with Cu(II) perchlorate in ethanol to yield [Cu(PDT)2(ClO4)2].
Application
3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine was employed as chromogenic-extraction reagent during spectrophotometric determination of iron in acids and acidic solutions. It was also employed as precolumn derivatizing reagent in the HPLC method with UV absorbance detection for the Fe(II) determination.
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Nikolay Polyakov et al.
Antioxidants & redox signaling, 28(15), 1394-1403 (2017-11-23)
Chemotherapy is currently the principal method for treating many malignancies. Thus, the development of improved antitumor drugs with enhanced efficacy and selectivity remains a high priority. Recent Advances: Anthracycline antibiotics (AAs), for example, doxorubicin, daunomycin, and mitomycin C, belong to
Sungsoon Hwang et al.
Retina (Philadelphia, Pa.), 39(6), 1117-1124 (2018-03-09)
To report the clinical outcomes of reduced-fluence photodynamic therapy (PDT) for symptomatic subfoveal retinal pigment epithelial detachment (RPED) in central serous chorioretinopathy and identify prognostic factors affecting treatment outcome. This retrospective interventional study included 35 eyes of 35 patients with
Yvonne H W Derks et al.
Theranostics, 11(4), 1527-1541 (2021-01-08)
Incomplete resection of prostate cancer (PCa) occurs in 15%-50% of PCa patients. Disease recurrence negatively impacts oncological outcome. The use of radio-, fluorescent-, or photosensitizer-labeled ligands to target the prostate-specific membrane antigen (PSMA) has become a well-established method for the
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 160415-5G | 04061838745521 |